Herpes Zoster

CDC committee recommends new shingles vaccine

CDC committee recommends new shingles vaccine

CDC voted for Shingrix over Zostavax as herpes zoster vaccine of choice

Herpes zoster linked to increased risk of cardiovascular events

Herpes zoster linked to increased risk of cardiovascular events

The risks of both stroke and myocardial infarction were highest the first year after the onset of herpes zoster and decreased with time.

Emergency department visits for herpes zoster increased from 2006-2013

Emergency department visits for herpes zoster increased from 2006-2013

The number of emergency department visits for herpes zoster have increased from 2006 to 2013.

At age 50, herpes zoster vaccine not cost-effective

At age 50, herpes zoster vaccine not cost-effective

For every 1,000 people aged 50 years that get the vaccine, only 25 cases of herpes zoster are prevented.

Could exposure to herpes zoster actually help clinicians? 


Could exposure to herpes zoster actually help clinicians? 


Herpes zoster represents the emergence of latent virus, specifically the varicella virus.

Shingles before 40 increases vascular risk

Shingles before 40 increases vascular risk

Risk for stroke, transient ischemic attack and myocardial infarction up in patients whose herpes zoster occurred before age 40 years.

Depression lowers efficacy of shingles vaccine

Depression lowers efficacy of shingles vaccine

Elderly patients with depression have diminished response to the shingles vaccine, but antidepressants may help.

Risk for shingles recurrence low in elderly

Risk for shingles recurrence low in elderly

Immunocompetent older people who have had shingles recently have a relatively low short-term risk for developing the skin condition again, regardless of vaccination status, study data show.

Shingles vaccine generally well tolerated in older adults

Shingles vaccine generally well tolerated in older adults

The shingles vaccine is safe and well tolerated in older adults, despite a small increased risk for allergic reaction in the week following vaccination.

Once-daily therapy for postherpetic neuralgia

Once-daily therapy for postherpetic neuralgia

Gralise significantly improved patient's mean pain scores compared with placebo in an 11-week clinical trial.

When to give the zoster vaccine

An elderly patient presented with an acute reaction of shingles. How soon after treatment is it advisable to administer the zoster vaccine (Zostavax)?

Managing post-herpetic neuralgia

A 55-year-old woman who had herpes zoster and takes morphine for post-herpetic neuralgia pain, no longer wants to be on heavy-duty pain medication. What are her alternatives?

Co-vaccination OK after all

Co-vaccination OK after all

By

Administering the herpes zoster and pneumococcal vaccines to patients during the same visit does not appear to compromise the effectiveness of the zoster vaccine.

Sign Up for Free e-newsletters